US2008124321A1PendingUtilityA1
ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL
Est. expiryJan 30, 2021(expired)· nominal 20-yr term from priority
C07K 2317/10C07K 16/00A61P 31/12A61P 31/04A61K 2039/505A61P 43/00C07K 16/065
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A new protein derived from acid hydrolyzed IgG concentrate which has a molecular weight of about 55,000, and is activated by heat within the defined narrow temperature range provides resulting product that has a protective mechanism for bacterial and viral invasion of living cells.
Claims
exact text as granted — not AI-modified1 . A treated and isolated IgG fraction, comprising:
acid hydrolyzed IgG fraction which has been heated for from 15 minutes to 1 hour at a temperature of from 35° C. to 40° C., and thereafter neutralized.
2 . The treated and isolated IgG fraction of claim 1 which has been hydrolyzed with from 0.1N to 0.2N acid.
3 . The treated and isolated IgG fraction of claim 2 wherein the acid is selected from the group consisting of hydrochloric acid, phosphoric acid and sulfuric acid.
4 . The treated and isolated IgG fraction of claim 1 which has a molecular weight of about 55,000.
5 . The treated and isolated IgG fraction of claim 1 wherein the IgG traction is derived from the sources selected from the group consisting of bovine or porcine blood or colostrum, egg or whey.
6 . The treated and isolated IgG fraction of claim 5 wherein the IgG is derived from bovine blood.
7 . The treated and isolated concentrate of claim 1 which is spray dried.
8 . A method of providing bacterial static and viral static activity, comprising:
oral dosing of a mammalian species with an anti-bacterial and antiviral effective amount of a treated and isolated IgG fraction which is acid hydrolyzed, and has been heated from 15 minutes to 1.0 hour at a temperature of 35° C. to 40° C., and thereafter neutralized.
9 . The method of claim 8 wherein the amount dosed is sufficient to provide a dosage of 0.25 mg/ml in the mammal's gut.
10 . The method of claim 8 wherein the dose is up to 5 grams/day.Join the waitlist — get patent alerts
Track US2008124321A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.